Skip to content

Ardelyx ARDX Finished goods

Finished goods at other companies

Bausch Health Companies logo
Bausch Health CompaniesBHC
$946M-2.0%
Aurinia Pharmaceuticals logo
Aurinia PharmaceuticalsAUPH
$4.33M+17.8%
Agios Pharmaceuticals logo
Agios PharmaceuticalsAGIO
$3.92M-2.5%
Amgen logo
AmgenAMGN
Neurocrine Biosciences logo
Neurocrine BiosciencesNBIX

Other financials

Income statement

See full
Revenue$94.5M+27.5%
Gross profit$89.7M+45.1%
Operating income-$32.8M+9.8%
Net income-$37.6M+8.6%
EPS (diluted)-$0.15+11.8%

Balance sheet

See full
Cash & equivalents$31.2M+1.3%
Total debt$208.3M+34.3%
Total equity$148.6M+2.0%
Total assets$504.5M+23.0%

Cash flow

See full
Operating cash flow-$32.2M+16.2%
CapEx$69.0K-78.8%
Free cash flow-$32.3M+16.7%

Valuation

See full
Market cap$1.53B+79.5%
Enterprise value$1.71B+74.8%
P/S3.6×+1.2×

Profitability

See full
Gross margin92.5%+7.9pp
Operating margin-25.4%
Net margin-13.6%
FCF margin-40.9%

Returns & leverage

See full
Return on equity-39.5%
Debt / equity1.4×+0.3×
Current ratio3.5×-0.6×

Where this comes from

Reported directly by Ardelyx in its filing.

Tagged under the XBRL concept us-gaap:InventoryFinishedGoods.

The official record: Ardelyx’s 10-Q, filed April 30, 2026, on SEC EDGAR. View the filing →

Ask your AI about Ardelyx's finished goods.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Ardelyx's finished goods?
Ardelyx (ARDX) reported finished goods of $10.04M in Q1 2026.
How has Ardelyx's finished goods changed year-over-year?
Ardelyx's finished goods increased by 134.9% year-over-year, from $4.28M to $10.04M.
What is the long-term trend for Ardelyx's finished goods?
Over 3 years (2022 to 2025), Ardelyx's finished goods has grown at a 111.5% compound annual growth rate (CAGR), from $723K to $6.84M.
What does finished goods mean?
Completed products ready for sale, valued at the lower of cost or net realizable value.